Adherium (ADR) Stock Overview
A digital health company, develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
ADR Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Adherium Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.0055 |
| 52 Week High | AU$0.015 |
| 52 Week Low | AU$0.003 |
| Beta | 1.12 |
| 1 Month Change | 10.00% |
| 3 Month Change | 37.50% |
| 1 Year Change | -63.33% |
| 3 Year Change | -92.67% |
| 5 Year Change | -98.33% |
| Change since IPO | -99.90% |
Recent News & Updates
Recent updates
Shareholder Returns
| ADR | AU Healthcare Services | AU Market | |
|---|---|---|---|
| 7D | -8.3% | -11.1% | -0.3% |
| 1Y | -63.3% | -22.6% | 5.9% |
Return vs Industry: ADR underperformed the Australian Healthcare Services industry which returned -22.6% over the past year.
Return vs Market: ADR underperformed the Australian Market which returned 5.9% over the past year.
Price Volatility
| ADR volatility | |
|---|---|
| ADR Average Weekly Movement | 32.3% |
| Healthcare Services Industry Average Movement | 11.4% |
| Market Average Movement | 9.4% |
| 10% most volatile stocks in AU Market | 17.6% |
| 10% least volatile stocks in AU Market | 3.3% |
Stable Share Price: ADR's share price has been volatile over the past 3 months compared to the Australian market.
Volatility Over Time: ADR's weekly volatility has increased from 24% to 32% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | n/a | Dawn Bitz | www.adherium.com |
Adherium Limited, a digital health company, develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. The company offers Hailie Smartinhaler, a system for management of chronic respiratory conditions, including asthma and chronic obstructive pulmonary disease. It also provides Hailie Smartinhaler sensors; Hailie Solution; and Hailie Remote Patient Monitoring (RPM) Solution.
Adherium Limited Fundamentals Summary
| ADR fundamental statistics | |
|---|---|
| Market cap | AU$17.00m |
| Earnings (TTM) | -AU$12.68m |
| Revenue (TTM) | AU$817.24k |
Is ADR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ADR income statement (TTM) | |
|---|---|
| Revenue | AU$817.24k |
| Cost of Revenue | AU$705.86k |
| Gross Profit | AU$111.37k |
| Other Expenses | AU$12.79m |
| Earnings | -AU$12.68m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0041 |
| Gross Margin | 13.63% |
| Net Profit Margin | -1,551.49% |
| Debt/Equity Ratio | -64.5% |
How did ADR perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/25 06:04 |
| End of Day Share Price | 2026/01/23 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Adherium Limited is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| John Hester | Bell Potter |
| Dennis Hulme | Edison Investment Research |
| Chris Kallos | MST Financial Services Pty Limited |